Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP869759.RALl9lMDVsfdVZcHjbXRp_mOd4vgL6MrUC4kHl3wkpy1o130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP869759.RALl9lMDVsfdVZcHjbXRp_mOd4vgL6MrUC4kHl3wkpy1o130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP869759.RALl9lMDVsfdVZcHjbXRp_mOd4vgL6MrUC4kHl3wkpy1o130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP869759.RALl9lMDVsfdVZcHjbXRp_mOd4vgL6MrUC4kHl3wkpy1o130_provenance.
- NP869759.RALl9lMDVsfdVZcHjbXRp_mOd4vgL6MrUC4kHl3wkpy1o130_assertion description "[Unexpectedly, these drugs did not suppress the growth of BRCA2-deficient pancreatic cancer cell lines from humans or gene-targeted mice expressing active Kras and trans-dominant inhibitory mutant Trp53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869759.RALl9lMDVsfdVZcHjbXRp_mOd4vgL6MrUC4kHl3wkpy1o130_provenance.
- NP869759.RALl9lMDVsfdVZcHjbXRp_mOd4vgL6MrUC4kHl3wkpy1o130_assertion evidence source_evidence_literature NP869759.RALl9lMDVsfdVZcHjbXRp_mOd4vgL6MrUC4kHl3wkpy1o130_provenance.
- NP869759.RALl9lMDVsfdVZcHjbXRp_mOd4vgL6MrUC4kHl3wkpy1o130_assertion SIO_000772 21289082 NP869759.RALl9lMDVsfdVZcHjbXRp_mOd4vgL6MrUC4kHl3wkpy1o130_provenance.
- NP869759.RALl9lMDVsfdVZcHjbXRp_mOd4vgL6MrUC4kHl3wkpy1o130_assertion wasDerivedFrom befree-2016 NP869759.RALl9lMDVsfdVZcHjbXRp_mOd4vgL6MrUC4kHl3wkpy1o130_provenance.
- NP869759.RALl9lMDVsfdVZcHjbXRp_mOd4vgL6MrUC4kHl3wkpy1o130_assertion wasGeneratedBy ECO_0000203 NP869759.RALl9lMDVsfdVZcHjbXRp_mOd4vgL6MrUC4kHl3wkpy1o130_provenance.
- befree-2016 importedOn "2016-02-19" NP869759.RALl9lMDVsfdVZcHjbXRp_mOd4vgL6MrUC4kHl3wkpy1o130_provenance.